BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29982334)

  • 1. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
    Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
    Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
    Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
    Cardoso L; Stevenson M; Thakker RV
    Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
    Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
    Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
    Arnold A
    Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic insights into sporadic primary hyperparathyroidism.
    Brewer K; Costa-Guda J; Arnold A
    Endocr Relat Cancer; 2019 Feb; 26(2):R53-R72. PubMed ID: 30475215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
    Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
    Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
    Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
    Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
    Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
    PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid Tumors: Molecular Signatures.
    Marini F; Giusti F; Iantomasi T; Brandi ML
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HRPT2 mutational analysis of typical sporadic parathyroid adenomas.
    Krebs LJ; Shattuck TM; Arnold A
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5015-7. PubMed ID: 15956079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
    Samander EH; Arnold A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular genetics of parathyroid neoplasms.
    Sharretts JM; Simonds WF
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):491-502. PubMed ID: 20833339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.